bpc-157 effects on the body Multifunctionality and Possible Medical Application of BPC 157 Peptide—Literature and Patent Review BPC-157 – No Proof Required!
Description
BPC-157 is not approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for human therapeutic use and is not intended to diagnose, treat, cure, or prevent any disease
Research protocols typically call for 2-5 mg per administration during loading phases
In the absence of formal oversight, purity, potency, sterility, and batch-to-batch consistency may vary considerablynot only among suppliers but also between production lots from the same manufacturer
In particular, besides uncertain translatability, many preclinical studies suffer from the lack of comparative evaluations between different delivery methods in one pathological model (i.e., oral vs
Pharmacol., 97(7), 589599 (2019)
This is one of the few human clinical data points for BPC-157 and, while small, it supports the direction of the preclinical work
